Details of the Drug Reposition

General Information of This Drug (ID: DMMZWGK)

Drug Name	KRN-23 DMMZWGK
Synonyms	Human mAb (injectable formulation, hypophosphatemia) Kyowa Hakko

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
X-linked hypophosphataemia	DISSKWCZ	5C63.22	Phase 3	[1]
Hypophosphatasia	DISCQ0O2	5C64.3	Phase 3	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT02526160) Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH).